Language Selection

Get healthy now with MedBeds!
Click here to book your session

Protect your whole family with Orgo-Life® Quantum MedBed Energy Technology® devices.

Advertising by Adpathway

         

 Advertising by Adpathway

Overweight Body Mass Index Linked to Lower Recurrence in Early-Onset Colorectal Cancer

1 day ago 1

PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY

Orgo-Life the new way to the future

  Advertising by Adpathway

A retrospective cohort study evaluating patients undergoing curative-intent surgery for colorectal adenocarcinoma has found that body mass index at diagnosis was statistically associated with the hazard of recurrence among individuals with early-onset colorectal cancer, but not among those with average-onset disease. Published in the International Journal of Colorectal Disease by researchers at Sahlgrenska University Hospital, the investigation revealed that younger patients falling within the overweight body mass index bracket experienced a lower rate of cancer recurrence than those with normal weight. When body mass index was evaluated as a continuous variable using restricted cubic splines, the overall association with recurrence in the early-onset group attained statistical significance with a likelihood-ratio test p-value of 0.048, and the pointwise ninety-five percent confidence intervals for the hazard ratio fell below unity between values of approximately 25 and 30 kilograms per square metre.

The study was established against a background of rising global incidence of early-onset colorectal cancer, defined as a diagnosis established before fifty years of age. Epidemiological records documented in the paper note that diagnoses among patients aged twenty to twenty-nine years escalated at an annual rate of 7.9 percent between 2004 and 2016, with early-onset disease projected to become the leading cause of cancer-related mortality in individuals aged twenty to forty-nine by the year 2040. While metabolic syndrome, physical inactivity, smoking, alcohol use, and diets rich in processed meats have been linked to colorectal cancer risk across age groups, the prognostic implications of excess body weight remain nuanced. Colorectal cancer literature has repeatedly documented an obesity paradox wherein overweight status correlates with improved survival despite obesity acting as a recognized risk factor for primary tumour development, yet whether this paradox applies directly to postoperative recurrence in younger cohorts remained unresolved.

To evaluate these dynamics, the research team analyzed electronic health records from Sahlgrenska University Hospital spanning 2011 through 2019, restricting inclusion to 1,821 consecutive patients who underwent radical surgical resection with curative intent for histologically confirmed colorectal adenocarcinoma. The analytic population comprised 158 patients categorized as early-onset cases diagnosed under fifty years of age and 1,663 patients categorized as average-onset cases aged fifty years or older. Exclusions were applied to patients undergoing non-radical resections, those with missing height, weight, recurrence, or covariate data, and fifteen individuals presenting with a body mass index exceeding 40 kilograms per square metre due to insufficient sample numbers to reliably calculate splines at extreme body mass distributions.

The demographic and clinical baselines highlighted distinct differences between the younger and older cohorts undergoing radical surgery. Early-onset patients presented with a mean age of 43.0 years compared to 71.1 years in the average-onset group, while male sex distributions were comparable across groups at 52.5 percent and 53.5 percent respectively. Categorized by World Health Organization thresholds, the early-onset group comprised 3 underweight individuals representing 1.9 percent, 79 normal-weight patients at 50.0 percent, 61 overweight patients at 38.6 percent, and 15 patients with obesity at 9.5 percent. In comparison, the average-onset cohort had 32 underweight patients at 1.9 percent, 744 normal-weight patients at 44.7 percent, 627 overweight patients at 37.7 percent, and 260 patients with obesity at 15.6 percent. Younger patients more frequently presented with advanced stage III or IV disease at 60.1 percent versus 44.4 percent and more frequently received adjuvant chemotherapy at 69.6 percent versus 36.7 percent.

Over a median follow-up period of 4.8 years for early-onset cases and 3.5 years for average-onset cases, postoperative recurrence was documented in 40 early-onset patients and 285 average-onset patients, corresponding to overall recurrence proportions of 25.3 percent and 17.1 percent respectively. Among early-onset patients, disease recurrence emerged in 26 of the 79 normal-weight individuals, representing 32.9 percent, compared with 10 of 61 overweight individuals, representing 16.4 percent, and 3 of 15 obese individuals, representing 20.0 percent, alongside one recurrence in the three underweight cases. The estimated five-year probability of remaining free of recurrence was 60.5 percent for normal-weight patients, 83.0 percent for overweight patients, and 78.6 percent for patients with obesity in the early-onset group, whereas five-year recurrence-free survival in the average-onset cohort remained tightly clustered between 74.4 percent and 76.6 percent across all weight categories.

The primary statistical analysis utilized multivariable Cox proportional hazards regression models adjusted for tumour stage and anatomical tumour location, with stratification across categories of tumour differentiation to prevent bias after Schoenfeld residual assessments indicated non-proportional hazards. Body mass index was modeled using restricted cubic splines with four knots placed at cohort-specific percentiles, applying a value of 21.75 kilograms per square metre as the baseline reference. In the early-onset cohort, the overall association between continuous body mass index and recurrence hazard yielded a likelihood-ratio test p-value of 0.048, while testing for potential nonlinearity was not statistically significant at p equals 0.08. Conversely, identical spline modeling in the average-onset cohort demonstrated no evidence of overall association, generating a p-value of 0.88, and no nonlinearity at p equals 0.91.

When assessing categorical risk through unadjusted Cox regression in the early-onset cohort, overweight patients exhibited a significantly reduced hazard of recurrence relative to normal-weight patients, yielding a hazard ratio of 0.41 with a ninety-five percent confidence interval of 0.20 to 0.86 and a p-value of 0.02. However, upon statistical adjustment for anatomical tumour location and baseline tumour stage, this categorical association attenuated and ceased to be statistically significant, demonstrating an adjusted hazard ratio of 0.53 with a ninety-five percent confidence interval of 0.23 to 1.19 and a p-value of 0.12. Furthermore, statistical tests assessing formal interaction between body mass index and cohort assignment revealed no statistically significant divergence between the young and older patient groups, returning a p-value of 0.11 in spline models and 0.12 in linear specifications.

Linear sensitivity and robustness analyses demonstrated consistent directional patterns but lacked independent statistical significance within the younger cohort. Evaluating body mass index as a continuous linear term generated an estimated hazard ratio of 0.67 per five-kilogram-per-square-metre increase among early-onset patients, with a ninety-five percent confidence interval spanning 0.43 to 1.07 and a p-value of 0.09. Similar hazards were observed across models with reduced parameter counts, models restricting analysis to patients with stages I through III disease, and models excluding individuals who underwent neoadjuvant therapy anticipated to induce downstaging, indicating that the general direction of the risk estimate remained stable across distinct clinical subsets.

In evaluating potential biological and methodological explanations for the findings, the authors emphasized that the observed associations do not demonstrate a direct causal protective effect of elevated body mass index. Reverse causation represents a prominent consideration, as patients presenting with more aggressive or advanced disease may have experienced clinically silent prediagnostic weight loss that lowered their body mass index measurement prior to surgery. In support of this mechanism, stage IV disease was present at diagnosis in 16.5 percent of normal-weight early-onset patients compared with only 1.6 percent of overweight patients, whereas metastatic distributions were uniform across weight categories in older patients. Differences in physiological body composition may also play a role, as body mass index cannot distinguish between skeletal muscle mass and adipose tissue, meaning younger individuals with higher metrics might maintain preserved muscularity, whereas older counterparts more frequently harbor sarcopenia or visceral adiposity.

The researchers underscored several methodological limitations that necessitate cautious interpretation of the findings. The early-onset cohort was constrained by a modest sample size of 158 patients and only 40 recorded recurrence events, generating approximately 5.7 events per model parameter, which introduces the possibility that the greater flexibility of restricted cubic splines contributed to statistical significance via model overfitting. Additionally, height and weight records were missing in 24.5 percent of early-onset and 21.5 percent of average-onset surgical cases, largely among emergency admissions, and variables addressing smoking history, systemic comorbidities, dietary factors, and molecular tumour profiles were unavailable for adjustment. The authors concluded that while body mass index at diagnosis was associated with recurrence in early-onset colorectal cancer, larger prospective studies integrating body composition measurements and prediagnostic weight trajectories are required to confirm these observations.

Subject of Research: Association between body mass index at diagnosis and recurrence risk in early-onset versus average-onset colorectal cancer

Article Title: Weighing the hazards: body mass index and recurrence in early-onset colorectal cancer

Article References: Delryd, E., Tran, A., Lindskog, E. B., & Ljungman, D. (2026). Weighing the hazards: body mass index and recurrence in early-onset colorectal cancer. International Journal of Colorectal Disease, 41(1), Article 186. https://doi.org/10.1007/s00384-026-05279-4

Image Credits: AI Generated

DOI: 10.1007/s00384-026-05279-4

Keywords: Colorectal cancer, Early-onset colorectal cancer, Average-onset colorectal cancer, Body mass index, Cancer recurrence, Obesity paradox, Overweight, Restricted cubic splines, Cox proportional hazards, Tumour stage, Reverse causation, Sahlgrenska University Hospital, Adenocarcinoma, Surgical oncology, Oncology epidemiology, Body composition

Read Entire Article

         

        

Start the new Vibrations with a Medbed Franchise today!  

Protect your whole family with Quantum Orgo-Life® devices

  Advertising by Adpathway